No Data
Express News | LivaNova PLC - Active Treatment Arm Showed Significant Improvement Despite Primary Endpoint Not Met
Express News | Recover Clinical Study Shows Meaningful Benefits of Livanova’s Vns Therapy System in Select Secondary Endpoints for Unipolar Patients With Treatment-Resistant Depression
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova's VNS Therapy System in Select Secondary Endpoints for Unipolar Patients With Treatment-Resistant Depression
"Laggard" Stocks With Expanding FCF Margins and Attractive FCF Yields – Goldman
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
Is Now The Time To Look At Buying LivaNova PLC (NASDAQ:LIVN)?